ATLASEvommune (EVMN) earnings date: Dec 10, 2026
Evommune (EVMN) reports earnings for the quarter ended Sep 30, 2026 on Thu, Dec 10, 2026. Analysts expect EPS of -$0.82.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on EVMN
| Last price | $6.73 (-1.2%) |
|---|---|
| Normal 1-day range (±1σ) | ±6.0% |
| Earnings beat history | Beat the EPS estimate in 1 of the last 4 reports |
These figures come from the same calibrated model and valuation as the Evommune stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Evommune reports on Dec 10, 2026. One email the day before, with ATLAS’s read on Evommune. You can switch it off at any time.
Alert me before EVMN reportsFree to start. Creating an account takes under a minute.
EVMN earnings at a glance
| Next report (confirmed) | Thu, Dec 10, 2026 |
|---|---|
| Time | Not stated |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.82 |
| Last report | Aug 6, 2026 · Miss |
| Beat rate (last 4 reports) | 1 of 4 (25%) |
| Average EPS surprise | -18.2% |
| Average move around a report | ±8.8% (last 4) |
| Sector | Healthcare · Biotechnology |
Evommune earnings history: last 4 reports
Evommune last reported on Aug 6, 2026: EPS of -$0.89 against an estimate of -$0.67 (-32.8% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 6, 2026 | -$0.67 | -$0.89 | -32.8% | Miss | +8.1% |
| Jun 17, 2026 | $3.12 | $3.16 | +1.3% | In line | +6.5% |
| Mar 5, 2026 | -$0.84 | -$1.43 | -70.2% | Miss | +12.3% |
| Dec 11, 2025 | -$11.35 | -$8.07 | +28.9% | Beat | -8.2% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for EVMN
See the fair value, the probability range and the earnings history of Evommune on its ATLAS page.
Evommune (EVMN) stock analysisPlans from €3.99 a month.
Evommune earnings: frequently asked questions
When does Evommune (EVMN) report earnings?
Evommune is scheduled to report on Thursday, December 10, 2026 (the time of day has not been stated). ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for EVMN?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.82 per share (USD). Estimates can change before the report.
How often does EVMN beat earnings estimates?
Of its last 4 reports with a recorded result, Evommune beat the EPS estimate 1 times; the average surprise was -18.2%. Past results do not predict the next one.
How much does EVMN move around earnings?
Over its last 4 reports the stock moved an average of 8.8% (absolute, from the close before the report day to the close after it), and finished higher 3 of 4 times.
Did Evommune beat earnings estimates last quarter?
Evommune last reported on Aug 6, 2026: EPS of -$0.89 against an estimate of -$0.67 (-32.8% surprise), a miss.
How much does EVMN usually move in a day?
On a normal trading day the ATLAS model puts EVMN’s one-day range at about ±6.0%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Thu, Dec 10, 2026
Educational information, not investment advice. Disclaimer